Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 € ↑0,24 (3,28%)
2026-06-05
DEL PRIS
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionRenaissance Technologies Llc
ManagerJames Simons
Latest Disclosed Ownership1,582,568 shares
Latest Disclosed Value $ 12,866,278
Renaissance Technologies Llc reports 13.55% decrease in ownership of KUR / Kura Oncology, Inc.

On May 14, 2026 - Renaissance Technologies Llc filed a 13F-HR form disclosing ownership of 1,582,568 shares of Kura Oncology, Inc. (DE:KUR) valued at $10,524,077 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,830,566 shares of Kura Oncology, Inc.. This represents a change in shares of -13.55% during the quarter. The current value of the position is $11,964,214 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F KURA ONCOLOGY COM 50127T109 1,582,568 -247,998 -13.55 12,866 -32.35 0.0201
2026-02-12 2025-12-31 13F KURA ONCOLOGY COM 50127T109 1,830,566 965,256 111.55 19,020 148.39 0.0295
2025-11-13 2025-09-30 13F KURA ONCOLOGY COM 50127T109 865,310 -191,700 -18.14 7,658 25.57 0.0101
2025-08-13 2025-06-30 13F KURA ONCOLOGY COM 50127T109 1,057,010 524,400 98.46 6,099 73.49 0.0081
2025-05-14 2025-03-31 13F KURA ONCOLOGY COM 50127T109 532,610 -65,200 -10.91 3,515 -32.48 0.0053
2025-02-13 2024-12-31 13F KURA ONCOLOGY COM 50127T109 597,810 491,700 463.39 5,207 151.13 0.0077
2024-11-13 2024-09-30 13F KURA ONCOLOGY COM 50127T109 106,110 -15,090 -12.45 2,073 -16.91 0.0031
2024-08-09 2024-06-30 13F KURA ONCOLOGY COM 50127T109 121,200 -119,000 -49.54 2,496 49,800.00 0.0042
2024-05-13 2024-03-31 13F KURA ONCOLOGY COM 50127T109 240,200 -37,900 -13.63 5 66.67 0.0081
2024-02-13 2023-12-31 13F KURA ONCOLOGY COM 50127T109 278,100 162,500 140.57 4 200.00 0.0062
2023-11-14 2023-09-30 13F KURA ONCOLOGY COM 50127T109 115,600 -72,500 -38.54 1 0.00 0.0018
2023-08-11 2023-06-30 13F KURA ONCOLOGY COM 50127T109 188,100 171,500 1,033.13 2 0.0029
2023-05-12 2023-03-31 13F KURA ONCOLOGY COM 50127T109 16,600 16,600 0 0.0003
2023-02-13 2022-12-31 13F KURA ONCOLOGY COM 50127T109 0 -124,500 -100.00 0 -100.00
2022-11-14 2022-09-30 13F KURA ONCOLOGY COM 50127T109 124,500 -20,500 -14.14 1,701 -36.00 0.0024
2022-08-12 2022-06-30 13F KURA ONCOLOGY COM 50127T109 145,000 -133,400 -47.92 2,658 -40.63 0.0031
2022-05-13 2022-03-31 13F KURA ONCOLOGY COM 50127T109 278,400 210,700 311.23 4,477 372.26 0.0053
2022-02-11 2021-12-31 13F KURA ONCOLOGY COM 50127T109 67,700 -106,400 -61.11 948 -70.93 0.0012
2021-11-12 2021-09-30 13F KURA ONCOLOGY COM 50127T109 174,100 -128,100 -42.39 3,261 -48.25 0.0042
2021-08-13 2021-06-30 13F KURA ONCOLOGY COM 50127T109 302,200 302,200 6,301 0.0079
2020-08-13 2020-06-30 13F KURA ONCOLOGY COM 50127T109 0 -85,271 -100.00 0 -100.00
2020-05-14 2020-03-31 13F KURA ONCOLOGY COM 50127T109 85,271 85,271 848 0.0008
2018-05-14 2018-03-31 13F KURA ONCOLOGY COM 50127T109 0 -89,294 -100.00 0 -100.00
2018-02-13 2017-12-31 13F KURA ONCOLOGY COM 50127T109 89,294 -177,106 -66.48 1,366 -65.70 0.0015
2017-11-13 2017-09-30 13F KURA ONCOLOGY COM 50127T109 266,400 176,400 196.00 3,983 375.87 0.0047
2017-08-11 2017-06-30 13F KURA ONCOLOGY COM 50127T109 90,000 10,800 13.64 837 20.09 0.0011
2017-05-12 2017-03-31 13F KURA ONCOLOGY COM 50127T109 79,200 48,600 158.82 697 285.08 0.0010
2017-02-13 2016-12-31 13F KURA ONCOLOGY COM 50127T109 30,600 6,200 25.41 181 18.30 0.0003
2016-11-14 2016-09-30 13F KURA ONCOLOGY COM 50127T109 24,400 11,100 83.46 153 325.00 0.0003
2016-08-12 2016-06-30 13F KURA ONCOLOGY COM 50127T109 13,300 13,300 36 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.